| Year |
Citation |
Score |
| 2023 |
Song J, Kim A, Hong I, Kim S, Byun WS, Lee HS, Kim HS, Lee SK, Kwon Y. Synthesis and biological evaluation of atropisomeric tetrahydroisoquinolines overcoming docetaxel resistance in triple-negative human breast cancer cells. Bioorganic Chemistry. 137: 106573. PMID 37229969 DOI: 10.1016/j.bioorg.2023.106573 |
0.345 |
|
| 2023 |
Wang CY, Qin F, Wang CG, Kim D, Li JJ, Chen XL, Wang HS, Lee SK. Novel lignans from Zanthoxylum nitidum and antiproliferation activity of sesaminone in osimertinib-resistant non-small cell lung cancer cells. Bioorganic Chemistry. 134: 106445. PMID 36893545 DOI: 10.1016/j.bioorg.2023.106445 |
0.354 |
|
| 2023 |
Byun WS, Lim H, Hong J, Bae ES, Lee SB, Kim Y, Lee J, Lee SK, Hong S. Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. PMID 36786551 DOI: 10.1021/acs.jmedchem.2c01115 |
0.35 |
|
| 2022 |
Bae ES, Byun WS, Ock CW, Kim WK, Park HJ, Lee SK. Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 157: 114039. PMID 36423542 DOI: 10.1016/j.biopha.2022.114039 |
0.388 |
|
| 2022 |
Lee JY, Yang H, Kim D, Kyaw KZ, Hu R, Fan Y, Lee SK. Antiproliferative Activity of a New Quinazolin-4(3)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland). 15. PMID 35745617 DOI: 10.3390/ph15060698 |
0.339 |
|
| 2021 |
Byun WS, Bae ES, Cui J, Park HJ, Oh DC, Lee SK. Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells. Biomedicines. 9. PMID 33920736 DOI: 10.3390/biomedicines9040436 |
0.365 |
|
| 2021 |
Aldonza MBD, Reyes RDD, Kim YS, Ku J, Barsallo AM, Hong JY, Lee SK, Ryu HS, Park Y, Cho JY, Kim Y. Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass. Scientific Reports. 11: 8016. PMID 33850249 DOI: 10.1038/s41598-021-87599-9 |
0.755 |
|
| 2020 |
Luu TT, Bach DH, Kim D, Hu R, Park HJ, Lee SK. Overexpression of AGR2 Is Associated With Drug Resistance in Mutant Non-small Cell Lung Cancers. Anticancer Research. 40: 1855-1866. PMID 32234873 DOI: 10.21873/anticanres.14139 |
0.335 |
|
| 2020 |
Aldonza MBD, Ku J, Hong JY, Kim D, Yu SJ, Lee MS, Prayogo MC, Tan S, Kim D, Han J, Lee SK, Im SG, Ryu HS, Kim Y. Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Science Advances. 6: eaav7416. PMID 32083171 DOI: 10.1126/Sciadv.Aav7416 |
0.755 |
|
| 2019 |
Jeong I, Song J, Bae SY, Lee SK. Overcoming the Intrinsic Gefitinib-resistance via Downregulation of AXL in Non-small Cell Lung Cancer. Journal of Cancer Prevention. 24: 217-223. PMID 31950021 DOI: 10.15430/JCP.2019.24.4.217 |
0.31 |
|
| 2019 |
Ryu H, Jin H, Ho JN, Bae J, Lee E, Lee SE, Lee S. Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer. Biological & Pharmaceutical Bulletin. 42: 66-72. PMID 30606990 DOI: 10.1248/bpb.b18-00545 |
0.351 |
|
| 2018 |
Byun WS, Jin M, Yu J, Kim WK, Song J, Chung HJ, Jeong LS, Lee SK. A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer. Biochemical Pharmacology. PMID 30292755 DOI: 10.1016/j.bcp.2018.10.002 |
0.33 |
|
| 2018 |
Bach DH, Luu TT, Kim D, An YJ, Park S, Park HJ, Lee SK. BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells. Molecular Therapy. Nucleic Acids. 12: 817-828. PMID 30153566 DOI: 10.1016/j.omtn.2018.07.016 |
0.345 |
|
| 2017 |
Aldonza MB, Hong JY, Lee SK. Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation. Experimental & Molecular Medicine. 49: e286. PMID 28104912 DOI: 10.1038/emm.2016.131 |
0.758 |
|
| 2016 |
Bae SY, Park HJ, Hong JY, Lee HJ, Lee SK. Down-regulation of SerpinB2 is associated with gefitinib resistance in non-small cell lung cancer and enhances invadopodia-like structure protrusions. Scientific Reports. 6: 32258. PMID 27558531 DOI: 10.1038/srep32258 |
0.351 |
|
| 2016 |
Aldonza MB, Hong JY, Alinsug MV, Song J, Lee SK. Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation. Oncotarget. PMID 27284014 DOI: 10.18632/oncotarget.9118 |
0.758 |
|
| 2015 |
Yang YJ, Baek JY, Goo J, Shin Y, Park JK, Jang JY, Wang SB, Jeong W, Lee HJ, Um HD, Lee SK, Choi Y, Rhee SG, Chang TS. Effective killing of cancer cells through ROS-mediated mechanisms by AMRI-59 targeting peroxiredoxin I. Antioxidants & Redox Signaling. PMID 26528922 DOI: 10.1089/ars.2014.6187 |
0.302 |
|
| 2015 |
Aldonza MB, Hong JY, Bae SY, Song J, Kim WK, Oh J, Shin Y, Lee SH, Lee SK. Correction: Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells. Plos One. 10: e0133922. PMID 26196696 DOI: 10.1371/journal.pone.0133922 |
0.752 |
|
| 2015 |
Aldonza MB, Hong JY, Bae SY, Song J, Kim WK, Oh J, Shin Y, Lee SH, Lee SK. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells. Plos One. 10: e0127841. PMID 26098947 DOI: 10.1371/journal.pone.0127841 |
0.742 |
|
| 2015 |
Song J, Kwon Y, Kim S, Lee SK. Antitumor activity of phenanthroindolizidine alkaloids is associated with negative regulation of Met endosomal signaling in renal cancer cells. Chemistry & Biology. 22: 504-15. PMID 25865310 DOI: 10.1016/j.chembiol.2015.03.011 |
0.346 |
|
| 2015 |
Bae SY, Hong JY, Lee HJ, Park HJ, Lee SK. Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer. Oncotarget. 6: 10146-60. PMID 25760142 |
0.378 |
|
| 2015 |
Ho JN, Byun SS, Lee S, Oh JJ, Hong SK, Lee SE, Yeon JS. Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells. The Journal of Urology. 193: 1016-22. PMID 25229559 DOI: 10.1016/j.juro.2014.09.007 |
0.38 |
|
| 2014 |
Hong JY, Park SH, Min HY, Park HJ, Lee SK. Anti-proliferative effects of evodiamine in human lung cancer cells. Journal of Cancer Prevention. 19: 7-13. PMID 25337567 |
0.306 |
|
| 2013 |
Lee S, Yoon CY, Byun SS, Lee E, Lee SE. The role of c-FLIP in cisplatin resistance of human bladder cancer cells. The Journal of Urology. 189: 2327-34. PMID 23313194 DOI: 10.1016/j.juro.2013.01.003 |
0.371 |
|
| 2013 |
Bae SY, Kim GD, Jeon JE, Shin J, Lee SK. Anti-proliferative effect of (19Z)-halichondramide, a novel marine macrolide isolated from the sponge Chondrosia corticata, is associated with G2/M cell cycle arrest and suppression of mTOR signaling in human lung cancer cells. Toxicology in Vitro : An International Journal Published in Association With Bibra. 27: 694-9. PMID 23147639 DOI: 10.1016/j.tiv.2012.11.001 |
0.308 |
|
| 2012 |
Jo SK, Hong JY, Park HJ, Lee SK. Anticancer Activity of Novel Daphnane Diterpenoids from Daphne genkwa through Cell-Cycle Arrest and Suppression of Akt/STAT/Src Signalings in Human Lung Cancer Cells. Biomolecules & Therapeutics. 20: 513-9. PMID 24009843 DOI: 10.4062/biomolther.2012.20.6.513 |
0.373 |
|
| 2012 |
Kim EH, Min HY, Chung HJ, Song J, Park HJ, Kim S, Lee SK. Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 50: 1060-5. PMID 22120505 DOI: 10.1016/j.fct.2011.11.008 |
0.409 |
|
| 2011 |
Hong JY, Chung HJ, Lee HJ, Park HJ, Lee SK. Growth inhibition of human lung cancer cells via down-regulation of epidermal growth factor receptor signaling by yuanhuadine, a daphnane diterpene from Daphne genkwa. Journal of Natural Products. 74: 2102-8. PMID 21916433 DOI: 10.1021/np2003512 |
0.313 |
|
| 2010 |
Yang SH, Van HT, Le TN, Khadka DB, Cho SH, Lee KT, Chung HJ, Lee SK, Ahn CH, Lee YB, Cho WJ. Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents. Bioorganic & Medicinal Chemistry Letters. 20: 5277-81. PMID 20667733 DOI: 10.1016/j.bmcl.2010.06.132 |
0.314 |
|
| 2001 |
Westenburg HE, Lee KJ, Lee SK, Fong HH, van Breemen RB, Pezzuto JM, Kinghorn AD. Activity-guided isolation of antioxidative constituents of Cotinus coggygria. Journal of Natural Products. 63: 1696-8. PMID 11141121 DOI: 10.1021/Np000292H |
0.44 |
|
| 2000 |
Cho KH, Pezzuto JM, Bolton JL, Steele VE, Kelloff GJ, Lee SK, Constantinou A. Selection of cancer chemopreventive agents based on inhibition of topoisomerase II activity. European Journal of Cancer (Oxford, England : 1990). 36: 2146-56. PMID 11044654 DOI: 10.1016/S0959-8049(00)00300-2 |
0.456 |
|
| 2000 |
Lee SK, Pezzuto JM. Evaluation of the potential of cancer chemopreventive activity mediated by inhibition of 12-O-tetradecanoyl phorbol 13-acetate-induced ornithine decarboxylase activity. Archives of Pharmacal Research. 22: 559-64. PMID 10615860 DOI: 10.1007/Bf02975326 |
0.532 |
|
| 1999 |
Chung HS, Chang LC, Lee SK, Shamon LA, Van Breemen RB, Mehta RG, Farnsworth NR, Pezzuto JM, Kinghorn AD. Flavonoid constituents of Chorizanthe diffusa with potential cancer chemopreventive activity Journal of Agricultural and Food Chemistry. 47: 36-41. PMID 10563845 DOI: 10.1021/Jf980784O |
0.509 |
|
| 1999 |
Lee SK, Luyengi L, Gerhäuser C, Mar W, Lee K, Mehta RG, Kinghorn AD, Pezzuto JM. Inhibitory effect of munetone, an isoflavonoid, on 12-O-tetradecanoylphorbol 13-acetate-induced ornithine decarboxylase activity. Cancer Letters. 136: 59-65. PMID 10211940 DOI: 10.1016/S0304-3835(98)00309-7 |
0.496 |
|
| 1999 |
Qiu SX, Lu ZZ, Luyengi L, Lee SK, Pezzuto JM, Farnsworth NR, Thompson LU, Fong HHS. Isolation and characterization of flaxseed (Linum usitatissimum) constituents Pharmaceutical Biology. 37: 1-7. DOI: 10.1076/Phbi.37.1.1.6320 |
0.452 |
|
| 1998 |
Lee SK, Qing WG, Mar W, Luyengi L, Mehta RG, Kawanishi K, Fong HH, Beecher CW, Kinghorn AD, Pezzuto JM. Angoline and chelerythrine, benzophenanthridine alkaloids that do not inhibit protein kinase C. The Journal of Biological Chemistry. 273: 19829-33. PMID 9677417 DOI: 10.1074/Jbc.273.31.19829 |
0.49 |
|
| 1998 |
Gamez EJ, Luyengi L, Lee SK, Zhu LF, Zhou BN, Fong HH, Pezzuto JM, Kinghorn AD. Antioxidant flavonoid glycosides from Daphniphyllum calycinum. Journal of Natural Products. 61: 706-8. PMID 9599286 DOI: 10.1021/Np9800203 |
0.45 |
|
| 1998 |
Ito A, Shamon LA, Yu B, Mata-Greenwood E, Lee SK, Van Breemen RB, Mehta RG, Farnsworth NR, Fong HHS, Pezzuto JM, Kinghorn AD. Antimutagenic Constituents of Casimiroa edulis with Potential Cancer Chemopreventive Activity Journal of Agricultural and Food Chemistry. 46: 3509-3516. DOI: 10.1021/Jf9802373 |
0.477 |
|
| 1997 |
Mbwambo ZH, Lee SK, Mshiu EN, Pezzuto JM, Kinghorn AD. Constituents from the stem wood of Euphorbia quinquecostata with phorbol dibutyrate receptor-binding inhibitory activity. Journal of Natural Products. 59: 1051-5. PMID 8946746 DOI: 10.1021/Np960412E |
0.435 |
|
| 1997 |
Long L, Lee SK, Chai H, Rasoanaivo P, Gao Q, Navarro H, Wall ME, Wani MC, Farnsworth NR, Cordell GA, Pezzuto JM, Douglas Kinghorn A. Novel bioactive phenanthrene derivatives from Domohinea perrieri Tetrahedron. 53: 15663-15670. DOI: 10.1016/S0040-4020(97)10058-8 |
0.447 |
|
| 1996 |
Tan GT, Lee S, Lee IS, Chen J, Leitner P, Besterman JM, Kinghorn AD, Pezzuto JM. Natural-product inhibitors of human DNA ligase I. The Biochemical Journal. 314: 993-1000. PMID 8615799 DOI: 10.1042/Bj3140993 |
0.457 |
|
| 1995 |
Gerhäuser C, Mar W, Lee SK, Suh N, Luo Y, Kosmeder J, Luyengi L, Fong HHS, KingHorn AD, Moriarty RM, Mehta RG, Constantinou A, Moon RC, Pezzuto JM. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nature Medicine. 1: 260-266. PMID 7585044 DOI: 10.1038/Nm0395-260 |
0.506 |
|
| Show low-probability matches. |